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Supplementary Figure Legends 
 
S-Fig. 1. Detect telomerase activity and expressions of hTERT wild-type, mutant and hTR. The 
TRAP assay was performed to evaluate the telomerase activity, qRT-PCR for mRNA level and Western 
blot analysis for protein expression. IMR90 was used as a reference to calculate fold change of hTERT 
mRNA and telomerase activity. Telomerase positive cell lines HT1080 and MDA231 were used as 
positive controls. 
 
S-Fig. 2. Effect of hTERT over-expressing on telomere length. Histograms to analyze effects of 
telomere length in indicated cell lines (for main Fig. 1). 
 
S-Fig. 3. hTERT shortens long telomeres in ALT+ cancer cells. Empty vectors or hTERT were 
expressed in ALT+ U2OS (A) and SAOS2 (C) cells. Correlation between the average TL at specific 
chromosomal ends in vector control cells and percent of TL change at the corresponding chromosomal 
ends in hTERT over-expressing cells. Each dot represents a chromosomal end. 30 cells were analyzed 
per cell line. B. TRF assays were performed to quantitative telomere length.  Genomic DNA was loaded 
to gel and transferred to a Nylon membrane followed by telomeric DNA probe hybridization. 
 
S-Fig. 4. Localizations of hTERT at long telomeres. ALT SAOS2 cells were processed for indirect 
immunofluorescence and telomeric DNA FISH. Images were captured with a 100x objective. hTERT 
(HA, green) localized at telomeres including those telomeres with high signal intensity (telomeric PNA 
probe, red). An enlarged co-localization focus of hTERT and a telomere with high signal intensity is 




S-Fig. 5. Overexpression of hTERT does not induce telomere dysfunctional foci. IMR90 cells 
transduced with empty vector, hTERT or POT1-shRNA were immunostained with anti- -H2AX mouse 
monoclonal antibody (red) together with anti-TRF1 antibody (green). The nuclei were counterstained 
with DAPI. POT1-shRNA is used as a positive control. 
 




